PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 05cef45ec156035a
Drug Approval Canada Name: PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR
Product Name: PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR
Status: Marketed
Status Date: 2019-10-29
Original Market Date: 2019-10-29
Din: 02487284
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.20
Atc Original: J05AR06 EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ
Atc Name: j 05 ar 06
Aig Number: 0352327001
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

EMTRICITABINE

200 MG

EFAVIRENZ

600 MG

TENOFOVIR DISOPROXIL FUMARATE

300 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

05cef45ec156035a

Type

Standard